dos and don'ts while taking semaglutide GLP-1 drugs such as tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Do's & Don'ts while taking

[12] Ciebiera M, Wodarczyk M, Ciebiera M, Zarba K, ukaszuk K, Jakiel G

Patients with liver or kidney conditions should exercise caution and only use glutathione injections under strict medical guidance

But its a game of whack-a-mole: New sites pop up all the time, and neither the NABP nor the FDA has reviewed them all

Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.

The corporate chef said that even if restaurants werent launching new menus to cater to the demographic, they would still likely pivot their marketing to target them